Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.430
-0.030 (-2.05%)
At close: Aug 24, 2026, 4:00 PM EDT
1.450
+0.020 (1.40%)
After-hours: Aug 24, 2026, 7:31 PM EDT

InMed Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
4.944.944.64.141.09-
Revenue Growth
285.22%7.50%11.18%279.61%--
Gross Profit
1.711.711.11.40.54-
Operating Income
-8.04-7.92-8.13-8.38-13.59-9.94
Net Income
-8.51-8.16-7.68-7.95-18.6-10.2
Earnings Per Share
-2.53-8.36-20.14-64.92-663.32-759.16
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
5.211.126.618.966.227.41
Total Debt
0.420.740.960.390.790.27
Net Cash (Debt)
4.7810.385.658.575.437.14
Net Cash Growth
23.47%83.62%-34.01%57.80%-23.98%29.08%
Net Cash Per Share
1.4210.6314.8369.96193.57531.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-7.46-7.77-6.99-7.28-15.58-9.79
Capital Expenditures
---0.01-0.16-0.04-0
Free Cash Flow
-7.46-7.77-7-7.45-15.62-9.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
34.53%34.53%23.95%33.93%49.89%-
Operating Margin
-162.75%-160.20%-176.92%-202.60%-1247.60%-
Pretax Margin
-158.55%-165.14%-166.79%-191.86%-1707.32%-
Profit Margin
-172.17%-165.14%-166.94%-192.18%-1707.32%-
FCF Margin
-150.88%-157.14%-152.14%-180.02%-1434.03%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
1.290.790.520.758.85-